INTS : Recherche

Votre recherche : [La BTT] AUTEUR égal Raife T
6 résultat(s)

Alex J, Roberts B, Raife T. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL. 2009;24:215-217.
Thèmes : Donneurs et activité de prélèvement ; maj-2010-04

Gottschall J, Raife T. Studies of thrombotic thrombocytopenic purpura: the role of the AABB Research Foundation grant. Transfusion. 2005;45:60S-63S.
Thèmes : Hémostase ; maj-2005-10

McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood. 2004;104:1534-1541.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes

Raife T, Atkinson B, Montgomery R, Vesely S, Friedman K. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion. 2004;44:146-150.
Thèmes : Hémostase ; Coagulation et fibrinolyse ; maj-2004-03

Snyder E, Raife T, Lin L, Cimino G, Metzel P, Rheinschmidt M, Baril L, Davis K, Buchholz DH, Corash L, Conlan MG. Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion. 2004;44:1732-1740.
Thèmes : Inactivation des pathogènes ; maj-2005-01

Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood. 2001;98:1346-1351.
Thèmes : Transfusion homologue ; Produits sanguins plaquettaires